A one-year-old girl suffered severe burns during a family BBQ, the contents of a deep fat fryer were spilt over the child, covering her with boiling hot fat.
In the burns unit, it soon became clear that the girl had allergic reactions to existing treatment products at the time.
Philippe Sollie, a pharmacist, contacted the head of the burns department and together they started developing a product to help.
This is howFlamigel®was originally developed. In 1999,Flamigel®obtained a CE mark.
Discover our history
2023
Joint Venture in Czechia
The creation of our Joint Venture in Czechia (Czech Republic).
2021
New affiliate in Ireland
We reached more than 100 Flenners and the opening of our affiliate in Ireland.
2020
20 Years of Flen Health
Celebration of 20 years of Flen Health! 20 years of successfully providing real medical solutions for real patient needs. New product launch: Flamigel® Repair + Protect Handgel.
2019
US Affiliate
Foundation of US affiliate. At this point, more than 100 motivated employees were working in six affiliates across the globe. The company’s product portfolio is distributed in over 25 countries worldwide.
2018
20th Birthday of Flamigel®
Flen Health celebrated the 20th birthday of Flamigel® and launched Flamigel® RT, a product developed to prevent skin breakdown during radiotherapy treatment.
2016
145,000kg of Wound and Skin Healing Ointment
The company held a workforce of 80 staff and brought 145,000kg of wound and skin healing ointment products into the market.
2012
Further Expansion
Flen Health opened affiliates in The Netherlands, Germany and in the UK.
2011
Luxembourg Headquarters
A second headquarters in Luxembourg was opened. Flen Health has continued to grow and develop internationally.
2009
Introducing Extracalm®
Flen Health introduced extracalm® to the market as well as its first headquarters in Belgium.
2005
New Products - Flaminal® Hydro/Forte
The company`s portfolio continued to grow with Flaminal®, another innovative wound healing treatment. Flaminal®Hydro, followed by Flaminal® Forte which led to another shift in the medical device market in Belgium, the UK and beyond.